Discontinued — last reported Q4 '19
JPMorgan Chase Loans collectively evaluated for impairment - associated allowance increased by 0.7% to $25.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $25.24B to $25.70B.
other_financing_receivable_allowance_for_credit_losses_c_414c67| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.13B | $17.98B | $17.09B | $17.87B | $18.22B | $20.65B | $22.47B | $22.16B | $22.71B | $23.29B | $24.21B | $25.24B | $24.86B | $25.52B | $25.70B |
| QoQ Change | — | -6.0% | -5.0% | +4.6% | +2.0% | +13.3% | +8.8% | -1.4% | +2.5% | +2.5% | +4.0% | +4.3% | -1.5% | +2.7% | +0.7% |
| YoY Change | — | — | — | -6.6% | +1.3% | +20.8% | +25.8% | +21.6% | +10.0% | +3.6% | +9.3% | +11.2% | +6.7% | +5.4% | +1.8% |